The FDA has taken Evofem Biosciences to task for allegedly playing fast and loose with the facts, accusing the biotech of overstating the benefits of its contraceptive Phexxi in a digital patient ...

Evofem Biosciences targets the women’s health market with specialty products addressing sexual and reproductive conditions. It developed PHEXXI, a hormone-free prescription contraceptive vaginal gel, ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, announced today ...

SAN DIEGO, Sept. 11, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (Evofem) (OTCID: EVFM) today announced the conclusion and exciting impact of its groundbreaking August 2025 "Say Vagina" campaign, ...

The tight financial times continue to hit the healthcare sector, specifically affecting pharma and biotech companies. Evofem Biosciences, a contraceptives drugmaker, announced a workforce reduction ...

In this article you are going to find out whether hedge funds think Evofem Biosciences, Inc. (NASDAQ:EVFM) is a good investment right now. We like to check what the smart money thinks first before ...

SAN DIEGO--(BUSINESS WIRE)--Women’s health innovator Evofem Biosciences, Inc. (Evofem or the Company) (OTCID: EVFM), today announced financial results for the fourth quarter and year ended December 31 ...

MOUNTAIN VIEW, Calif. & SAN DIEGO--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), an innovation platform dedicated to accelerating promising health innovations, today ...

SAN DIEGO, Aug. 20, 2024 /PRNewswire/ -- As the popularity of GLP-1 receptor agonists continues to surge in the treatment of obesity and type 2 diabetes, Evofem Biosciences, Inc. (EVFM) is raising ...

SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- On World Contraception Day, Evofem Biosciences, Inc. (EVFM) honors the millions of people worldwide who rely on contraception not only to prevent pregnancy, ...